ASND financials
Ascendis Pharma (ASND) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ASND income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $691.71M | $588.53M | -$130.89M | -$219.03M | -3.62 |
| 2024 | $363.64M | $319.38M | -$278.76M | -$378.08M | -6.53 |
| 2023 | $266.72M | $222.32M | -$455.54M | -$481.45M | -8.55 |
| 2022 | $51.17M | $39.04M | -$561.81M | -$583.19M | -10.40 |
| 2021 | $7.78M | $4.25M | -$451.79M | -$383.58M | -7.00 |
| 2020 | $6.95M | $6.95M | -$330.62M | -$418.95M | -8.28 |
- ASND revenue was $691.71M in fiscal 2025, net income -$219.03M.
Updated 2026-11-03 02:02 UTC